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Edited by Julian SchroederAbstract Although the cyclic nucleotide-modulated potassium
channel from Mesorhizobium loti, MlotiK1, is easily studied
using a 86Rb+ ﬂux assay, its comparatively low activity raises
serious concerns about the integrity of the puriﬁed protein. We
investigated the pathway of uptake using a multi-pronged
approach. First, we probed the conduction pathway using
quaternary ammonium compounds known to block conduction
in eukaryotic K+ channels. Second, we examined the eﬀect of
chemical modiﬁcation of putative pore-lining residues. Our
results are consistent with ions traversing MlotiK1 along a con-
duction pathway like that of the eukaryotic channels, but at a
much slower rate.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Polyamine; Potassium channel1. Introduction
Ion channel proteins modulated directly by intracellular cyc-
lic nucleotides (CN channels) play pivotal roles in many
eukaryotic cell types [1]. Genes encoding CN channels are also
found in several bacterial species, but the native function(s) of
prokaryotic CN channels remains unknown [2,3]. One of these
proteins, the MlotiK1 channel from Mesorhizobium loti, is
experimentally amenable to milligram-scale expression and
puriﬁcation [4]. The soluble cyclic nucleotide binding domains
(CNB domains) from MlotiK1 have been crystallized in both
liganded and unbound conformations [5,6], and the combina-
tion of these two structures provides an unique framework for
understanding the molecular basis of modulation by cyclic
nucleotide.
Prokaryotic channel function is typically studied with elec-
trophysiological recordings or through radioactive ﬂux assays
[7–9]. MlotiK1 activity has proven stubbornly resistant to the
former approach, but has yielded to the latter [4,5]. MlotiK1
mediates 86Rb+ uptake into proteoliposomes, and it displays
the nucleotide-dependent activity expected of a CN channel
[4,6,7,10,9]. However, the kinetics of uptake are at least 60-fold*Corresponding author.
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slow kinetics, coupled with an inability to see activity of the
puriﬁed MlotiK1 channel in planar lipid bilayers, raises a con-
cern about the physical nature of 86Rb+ translocation in the
uptake assay: perhaps uptake is not through the normal con-
duction pathway, but rather reﬂects 86Rb+ ‘‘sneaking’’ through
the membrane in a MlotiK1-dependent fashion, possibly along
the bilayer–protein interface.
These experiments use compounds known from functional
and structural studies to act along the central symmetry axis
that forms the conserved conduction pathway of potassium
channels to reexamine the functional pathway of ion transloca-
tion mediated by MlotiK1.2. Materials and methods
2.1. Materials and reagents
Decylmaltoside was obtained from Anatrace (Maumee, OH, USA),
E. coli polar lipids from Avanti Polar Lipids (Alabaster, AB, USA),
PA and QA compounds from Fluka (Ronkonkoma, NY, USA),
86Rb+ from GE Healthcare (Piscataway, NJ, USA), cAMP, bME,
DTT, and imidazole from Sigma Chemical Co. (St. Louis, MO,
USA), and MTSEA from Toronto Research Chemicals (North York,
ON, Canada).
2.2. Clones and mutagenesis
The WT and cysteine-free MlotiK1 genes with C-terminal hexahista-
dine tags in the pASK90 expression plasmid were described previously
[5,6]. Cysteine mutations were generated using QuikChange mutagene-
sis (Stratagene, La Jolla, CA) and conﬁrmed by DNA sequencing.
2.3. Expression and puriﬁcation
Expression and puriﬁcation were adjusted from [5,6] as follows:
membrane protein was solubilized with 25 mM DM and bound to
Ni2+-matrix in the presence of 25 mM imidazole (pH 7.8). Wash and
elution buﬀers contained 5 mM DM, 25 mM imidazole (pH 7.8) or
5 mM DM, 500 mM imidazole (pH 7.0), respectively. 5 mM bME
was used as the reducing agent throughout, except for studies of the
A211C single cysteine mutant, where it was omitted from the ﬁnal size
exclusion chromatography run and all subsequent steps.
2.4. Functional assays
Flux assays were performed as described [6] on MlotiK1 reconsti-
tuted into E. coli polar lipid at 5 lg protein per mg lipid. Time course
data are presented as means ± S.D., n = 3, from a single day, with sim-
ilar data obtained on three separate days. All other data are shown as
means ± S.E., performed in triplicate 2–9 times. Where not visible, er-
ror bars are smaller than symbols. Diﬀerent preparations displayed
variability in the ‘‘leakiness’’ of control vesicles (in the absence of pro-
tein) and the total fraction of vesicles that contain MlotiK1. By focus-
ing on either protein-dependent or cAMP-dependent activity, our
experiments avoided complications due to this variability.
Channel blockers were added to extraliposomal solutions from 100·
stocks dissolved in sorbitol buﬀer immediately prior to addition of
86Rb+. Uptake was monitored after 1.5 h.ation of European Biochemical Societies.
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with 1 mM MTSEA for 30 min prior to exchanging extraliposomal
KCl with sorbitol.1.0
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A3. Results
3.1. Permeation through MlotiK1
MlotiK1 activity is studied using a radioactive ﬂux assay
similar to that previously used with other puriﬁed and recon-
stituted channels including KcsA and ClC0 [4,5,10–12]. In
brief, an uneven distribution of K+ across the liposomal mem-
brane generates a diﬀusion potential that drives 86Rb+ uptake
(Fig. 1A). As shown in Fig. 1B, MlotiK1 displays basal activity
in the absence of exogenous ligand that is stimulated roughly
2-fold by the addition of a saturating concentration of cAMP.
In the experiments that follow, we consider the diﬀerent com-
ponents of activity in detail. We use the term ‘‘basal activity’’
to refer to that induced by MlotiK1 protein reconstituted in
the absence of cAMP, and deﬁne it experimentally as the dif-
ference in uptake between control liposomes and vesicles con-
taining MlotiK1 (Fig. 1B). In contrast, ‘‘cAMP-dependent
uptake’’ is used to described the uptake induced by addition
of exogenous cAMP to the uptake assay, and is practically de-
ﬁned as the increase in uptake observed with the addition of
maximally-stimulating concentrations of cAMP (Fig. 1B).
Even in the presence of saturating cAMP uptake does not
saturate over the 3 h time period, raising the question of
whether transport occurs along a properly folded and func-
tional pore.0.0 1.0 2.0 3.0
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Fig. 1. Schematic (A) and raw data (B) illustrating the 86Rb+ uptake
assay. (A) Upon removal of extra-liposomal K+, the K+ gradient sets
up an inside-negative diﬀusion potential in any liposome containing
active channels. 86Rb+ added to the outside of the liposome will diﬀuse
through MlotiK1 and be concentrated inside the vesicles according to
the diﬀusion potential. Finally, 86Rb+ content is quantiﬁed after
removing extraliposomal 86Rb+. (B) Time course of uptake into
control liposomes (containing no protein, ,) or proteoliposomes
reconstituted with MlotiK1 in the absence (d) or presence (n) of
100 lM cAMP. Total liposomal space was determined by measuring
86Rb+ uptake into an aliquot of vesicles treated with valinomycin, and
was used to compare diﬀerent vesicles preparations to provide
‘‘normalized uptake’’.3.2. Inhibition by pore-blocking compounds
K+ channels are commonly inhibited by two diﬀerent classes
of compounds, QAs and PAs. Both act by physically occluding
the conduction pore, and are thus well-suited for examining
permeation through MlotiK1. The functional eﬀects of the
compounds on uptake are easily examined by adding them
to the outside of vesicles immediately prior to the addition
of 86Rb+.
We ﬁrst examined the eﬀect of symmetric QAs on both basal
and cAMP-stimulated activity. As shown in Fig. 2A and B, the
potency of the QA compounds increased with their physical
size; in both cases, TBA was the most potent, followed by
TPrA, and TEA had no eﬀect over the concentration range
tested. Although cAMP-dependent activity was completely
inhibited by high concentrations of TBA (Fig. 2B), roughly
30% of the basal activity remained in the presence of saturating
TBA (Fig. 2A).
The PAs putrescine, cadaverine and spermidine (Fig. 3A)
were tested at a single concentration (100 lM) on total uptake
observed in the presence of cAMP. All three compounds dra-
matically reduced ﬂux by comparison with that observed in
control vesicles (Fig. 3B).0.0
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Fig. 2. Inhibition of MlotiK1 by QA compounds. cAMP-dependent
uptake was evaluated in the presence of the indicated concentrations of
TEA (n), TPrA (d), or TBA (m). cAMP-dependent uptake was
determined as the diﬀerence between total and basal uptake at each
concentration of QA. QAs were added to the uptake assay immediately
before the addition of 86Rb+ from stock solutions containing 100 times
the ﬁnal desired concentration, and uptake was quantiﬁed after a 1.5 h
incubation. Data were ﬁtted to a one:one binding isotherm;
uptake = A + [(1  A)/(1+[QA]/K1/2)] to provide the following values
for A and K1/2 (lM): Basal: TEA: A = 1, K1/2 = 230; TPrA: A = 0.4,
K1/2 = 8.6; TBA: A = 0.3, K1/2 = 2.3; cAMP-dependent: TEA: not ﬁt;
TPrA: A = 1, K1/2 = 70; TBA: A = 1, K1/2 = 2.0.
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Fig. 3. Eﬀects of polyamines on MlotiK1-mediated uptake. (A)
Chemical structures of putrescine (PUT), cadaverine (CAD) and
spermidine (SPD). (B) Eﬀect of 100 lM PUT, CAD or SPD on total
(basal + cAMP-dependent) MlotiK1-mediated uptake in the presence
of 100 lM cAMP. Uptake into vesicles containing no protein is shown
for comparison. Individual samples were normalized by the average
uptake measured in the presence of cAMP on the same day. Data are
means ± S.E.M. (+cAMP, n = 17; PUT, n = 7; CAD, n = 6; SPD,
n = 3; no protein, n = 11.)
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The pores of even distantly related channels contain substan-
tial homology at the level of primary sequence (Fig. 4A). We
used this homology, together with the KcsA and MthK crystal
structures ([13,14] thought to represent closed and open chan-
nel conformations, respectively) as a basis for predicting the
disposition of speciﬁc MlotiK1 residues (Fig. 4A). Speciﬁcally,
A211 should lie within the cytoplasmic vestibule of MlotiK1
(Fig. 4B). Working with a cysteine-less MlotiK1 construct,
we generated the A211C mutation to test whether chemical
modiﬁcations of this side chain would aﬀect channel function.
Methanethiosulfonate (MTS) reagents have proven utility in
mapping the surface of the conduction pathway in many ion
channels. MTSEA is membrane-permeant, and therefore par-
ticularly suitable for use on MlotiK1 protein reconstituted into
vesicles, where the absolute orientation of channel remains un-
known. Incubation of 1 mM MTSEA with vesicles containing
the A211C mutant protein in the presence of cAMP reduced
uptake to that of control vesicles containing no protein
(Fig. 4C). Although unreacted MTS reagent is not removed
from the interior of the vesicle sample in these experiments,
two control experiments demonstrate that MTSEA acts
through a covalent modiﬁcation of the cysteine side chain.
First, activity of MTSEA-treated A211C protein was recov-
ered by a 30 min incubation with the membrane-permeant
reducing agent DTT (Fig. 4C), and second, the eﬀect of
MTSEA requires the cysteine sidechain, as MTSEA has no ef-
fect on uptake by the cysteine-free MlotiK1 channel (Fig. 4D).
These experiments were conducted in the presence of cAMP,
but the ﬁnding that MTSEA reduces uptake to the level ob-served in the no-protein control indicates that it must inhibit
both basal and cAMP-dependent uptake.
If A211C is indeed readily reactive, then we should be able
to observe its reaction with MTSEA directly during the course
of an experiment. As expected, acute treatment of vesicles with
MTSEA stalls subsequent uptake (Fig. 4E), while MTSEA-
inhibited uptake can be recovered by the addition of 10 mM
DTT (Fig. 4F). These results indicate that the MTSEA reac-
tion and subsequent reduction by DTT are both rapid pro-
cesses compared to the slow time-course of Rb+ uptake.4. Discussion
We used two parallel approaches, functional studies of chan-
nel inhibitors and site-speciﬁc chemical modiﬁcation, to verify
that 86Rb+ uptake proceeds along the central conduction path-
way.
QAs and PAs are distinct classes of potassium channel inhib-
itors. With the notable exception of TEA, these compounds in-
hibit K+ channels only from the intracellular side [1,15].
Structure–function studies in numerous K+ channels ﬁrmly
establish that both QA and PA compounds bind within the
conduction pathway and physically occlude ion translocation
[16–18]. QA compounds are generally more speciﬁc for potas-
sium channels, while PAs inhibit a variety of eukaryotic chan-
nels, including inward rectiﬁer K+ channels, cyclic-nucleotide
gated channels, ionotropic glutamate receptors, and Na+ and
Ca2+ channels [19]. The eﬀects of QAs on MlotiK1-mediated
ﬂux exactly mirror their actions on the related eukaryotic
channels. TEA typically has modest (mM) aﬃnity in K+ chan-
nels; we did not observe inhibition up to the practial limitation
of this assay of 100 lM. Other QA compounds display the
same order of eﬃcacy in MlotiK1 as they do at the internal
vestibule of eukaryotic K+ channels [20], with K1/2 decreasing
as hydrophobicity increases. Moreover, the actual values for
K1/2 observed in MlotiK1 (2 lM and 70 lM for TBA and
TPrA, respectively) are even lower than those found in eukary-
otic channels (with apparent dissociation constants of 32 lM
and 650 lM, respectively in the delayed rectiﬁer K+ channel
of the squid giant axon [20]). The eﬀect of polyamines in Mlo-
tiK1 is particularly reminiscent of that observed in the cyclic
nucleotide-gated channel CNGA1 [21]: inhibition occurs in
the micromolar concentration range, and spermidine acts more
strongly than putrescine. The selectivity and aﬃnity of the QA
eﬀects are most easily explained if, like in traditional K+ chan-
nels, MlotiK1 facilitates translocation along a central conduc-
tion pore and the QAs bind along that axis.
Our observation of inhibition of A211C mutant protein by
MTSEA provides independent evidence of functional similar-
ity between MlotiK1 and related channels. MTS compounds
have been used extensively to examine gating and conduction
in numerous channels homologous to MlotiK1. In the three
eukaryotic channels Shaker, CNGA1, and SpHCN, there are
functional consequences of modifying the residue analogous
to A211 in MlotiK1 (V478 in Shaker, G395 in CNGA1,
T464 in SpHCN) [22–24].
The data from both inhibitor and chemical modiﬁcation
experiments of MlotiK1 closely mirror that from homologous
K+ channels. We do not yet understand the structural basis of
basal activity observed in the absence of exogenous cAMP; it
may reﬂect a very low open probability, an open state with a
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Fig. 4. Chemical modiﬁcation of MlotiK1. (A) Sequence alignment of selectivity ﬁlter and adjacent transmembrane helix from related channels. The
conserved glycine hinge is highlighted. A211 in MlotiK1 is shown with a w. Sequences and their accession numbers are: MlotiK1 (gi: 14023393),
KcsA (gi: 1089905), Drosophila Shaker, (dShaker; gi: 157064), rat Kv2.1 (rKv2.1; gi: 6981120), MthK (gi: 2622632), human Slo (hSlo; gi: 46396283),
bovine CNGA1 (bCNGA1; gi: 27805875), bovine CNGA2 (BCNGA2; gi: 287744), and sea urchin HCN (SpHCN; gi: 3242324). (B) The structures of
KcsA (left) and MthK (right), with front and rear subunits removed for clarity. b-Carbons of residues analogous to A211 shown in CPK (KcsA,
A111; MthK, L95). Structures were drawn using Molscript from PDB ﬁles 1BL8 (KcsA) and 1LNQ (MthK). (C,D) Uptake into liposomes in the
presence of 0.1 mM cAMP containing A211C (C) or cysteine-less (D) MlotiK1. An aliquot of liposomes was pretreated with MTSEA prior to the
uptake assay. In the case of A211C, an MTSEA-treated aliquot was further incubated with 5 mM DTT for 30 min prior to use. (E) Time course of
MTSEA inhibition of uptake into vesicles containing A211C mutant protein in the presence of 0.1 mM cAMP. MTSEA was added from a 100· stock
to an aliquot of vesicles () at a ﬁnal concentration of 300 lM at the time indicated by the arrow. Uptake into untreated A211C-containing vesicles
was also monitored for a similar time (n). (F) Time course of reversing MTSEA inhibition in the presence of 0.1 mM cAMP. Vesicles containing
A211C MlotiK1 were treated with MTSEA prior to initiation of uptake. At the time indicated by the arrow, DTT was added to one aliquot (m) at a
ﬁnal concentration of 10 mM from a 1 M stock solution, while the other untreated aliquot served as a control (,).
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tion of the basal activity and all the cAMP-dependent compo-
nent are blocked by QA ions and MTS reagents is most simplyexplained if the principal transport pathway through MlotiK1
for basal and cAMP-mediated uptake occurs along the canon-
ical conduction pore conserved in the related K+ channels. The
5028 W.R. Silverman, L. Heginbotham / FEBS Letters 581 (2007) 5024–5028question of where the small fraction of basal uptake which is
resistant to QA ions originates remains open; it seems unlikely
to proceed through the conduction pore, but may instead come
from ion movement along the lipid–protein interface.
If MlotiK1 conducts ions along the same pathway as other
K+ channels, it is unclear why conduction through MlotiK1
is so slow. In the experiments shown here at least part of the
answer may reﬂect our use of 86Rb+ as the tracer. Both K+
and Rb+ traverse the same permeation pathway in K+ chan-
nels [25], and K+ channels are generally equally permeant to
Rb+ and K+ under biionic conditions [26,27]. Yet kinetically
there are often diﬀerences between the two ions: Rb+ can have
a 10–15-fold lower conductance than K+ [27]. We used 86Rb+
for practical reasons; our experiments focused on the physical
nature of the permeation pathway and not the kinetics of the
permeation process, and 86Rb+ is far more experimentally sui-
ted than 42K+ (with a half-life of 19 days as compared to
12 h for 42K+).
Finally, we wonder whether polyamines might modulate
prokaryotic channels in vivo. The physiological function of
the related inward-rectiﬁer K+ (KIR) channels depends on
intracellular block by the native polycationic polyamines
spermine, spermidine, putrescine, and cadaverine [19]. PAs
are clearly important in prokaryotic physiology, where they
play roles in cell division and proliferation, and protein synthe-
sis [28,27,26]. The compounds are found in relatively high
abundance: levels of spermidine and putrescine are 20- and
8000-fold higher, respectively, in E. coli than in eukaryotic
brain tissue [28,29]. Similar PA concentrations inMesorhizobi-
um loti would undoubtedly aﬀect the native activity of Mlo-
tiK1.
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